Lacosamide has an elimination half-life of about 13 hours, meaning your body clears half the drug from your bloodstream roughly every 13 hours. Based on the standard pharmacology rule that it takes about five half-lives to fully eliminate a medication, lacosamide stays in your system for approximately 65 hours, or just under 3 days, after your last dose.
How the 13-Hour Half-Life Works
After you take a dose of lacosamide, it reaches peak levels in your blood within about 1 to 4 hours. From there, your body begins breaking it down and filtering it out at a steady rate. Every 13 hours, the concentration drops by half. So if you stopped taking it, here’s roughly what happens:
- 13 hours after last dose: 50% remains
- 26 hours: 25% remains
- 39 hours: 12.5% remains
- 52 hours: about 6% remains
- 65 hours (~2.7 days): about 3% remains, considered functionally eliminated
This timeline applies whether you took lacosamide as a tablet or received it intravenously. The 13-hour half-life stays the same regardless of dose size, how long you’ve been on the medication, or which form you used.
Steady State and What It Means for Stopping
If you take lacosamide twice daily as prescribed, the drug reaches a steady state in your blood after about 3 days. At steady state, the amount entering your system with each dose roughly equals the amount being eliminated between doses, so your blood levels stay within a consistent range.
This matters for the elimination question because once you’re at steady state, your body has a higher total drug load than after a single dose. Still, the 13-hour half-life governs how quickly levels fall. Within about 3 days of your final dose, blood concentrations will drop to negligible levels for most people.
How Your Body Processes Lacosamide
Your kidneys do the heavy lifting. About 95% of a lacosamide dose is recovered in urine, with less than 0.5% exiting through feces. Of what shows up in urine, roughly 40% is the unchanged drug itself, 30% is a primary breakdown product, and another 20% appears as a secondary metabolite. Your liver handles the initial metabolism before the kidneys filter everything out.
Liver and Kidney Problems Slow Elimination
If your liver or kidneys aren’t working at full capacity, lacosamide will stay in your system longer than the typical 3-day window.
People with moderate liver impairment show blood concentrations 50 to 60% higher than those with healthy liver function after the same dose. That higher drug exposure means the effective clearance time stretches beyond the usual estimate. Lacosamide has not been studied in people with severe liver disease and is generally not recommended for that group.
Kidney impairment has a similar slowing effect, since the kidneys are responsible for excreting nearly all of the drug and its metabolites. If your kidney function is reduced, expect the drug to linger longer. Dialysis does remove lacosamide from the blood, which can shorten clearance time for people on that treatment.
Other Medications Can Speed Things Up
Certain anti-seizure drugs that are known enzyme inducers, including carbamazepine, phenytoin, and phenobarbital, can increase the rate at which your body clears lacosamide. In adults, taking one of these alongside lacosamide boosts clearance by about 34%. In children and teenagers, the effect is even larger, around 53%.
A 34% faster clearance in adults translates to a modestly shorter half-life, meaning the drug would leave your system somewhat sooner than the standard 65-hour estimate. However, the FDA notes these interactions aren’t large enough to require dose adjustments in most cases. If you’re not taking any enzyme-inducing medications, the standard 13-hour half-life applies.
Urine Detection Window
Since 40% of each dose is excreted unchanged in urine, lacosamide is detectable in a urine sample for roughly the same 2.5 to 3 day window after your last dose. The breakdown products may be detectable slightly longer, but standard drug screening panels do not typically test for lacosamide. If you’re being monitored through therapeutic drug levels (a blood draw), the reference range used in clinical practice is roughly 6.5 to 12 micrograms per milliliter, depending on whether the sample is taken at the drug’s lowest point before your next dose or at its peak.